The goal of the AIM Study is to compare these two effective treatments to see which is more effective at reducing drinking, and to learn more about how they work. To learn how the interventions work, ...
(“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions ...
A study links COVID-19 infection to higher ME/CFS rates, supporting Ampligen's potential as a treatment for affected individuals. AIM ImmunoTech Inc. has commented on a recently published study in ...
The proje ct aims to be a corrective to Jewish studies ... had a deep impact on Wassner that she says enriches her field of study. “I think I understand these questions in a very personal ...
Jan. 23, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and ...